Zevra Therapeutics Inc
F:1GDA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Z
|
Zevra Therapeutics Inc
F:1GDA
|
US |
|
I
|
Installed Building Products Inc
F:2IL
|
US |
|
V
|
Vector Group Ltd
F:VGR
|
US |
|
O
|
OFS Capital Corp
F:9UD
|
US |
|
G
|
Granite Construction Inc
F:GRG
|
US |
Wall St Price Targets
1GDA Price Targets Summary
Zevra Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for 1GDA is 18.72 EUR with a low forecast of 13.78 EUR and a high forecast of 23.87 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1GDA's stock price target?
Price Target
18.72
EUR
According to Wall Street analysts, the average 1-year price target for 1GDA is 18.72 EUR with a low forecast of 13.78 EUR and a high forecast of 23.87 EUR.
What is the Revenue forecast for Zevra Therapeutics Inc?
Projected CAGR
22%
The compound annual growth rate for Revenue over the next 8 years is 22%.
What is the Gross Profit forecast for Zevra Therapeutics Inc?
Projected CAGR
21%
The compound annual growth rate for Gross Profit over the next 8 years is 21%.
What is the Pre-Tax Income forecast for Zevra Therapeutics Inc?
Projected CAGR
28%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 28%.
What is the Net Income forecast for Zevra Therapeutics Inc?
Projected CAGR
19%
The compound annual growth rate for Net Income over the next 8 years is 19%.
